Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Retinoblastoma × Lasers × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Breast Neoplasms 3 Warts 2 Neurofibromatosis 1 2 Neoplasms 2 Stomatitis 1 Squamous Cell Carcinoma of Head and Neck 1 Retinoblastoma 1 Retinal Neoplasms 1 Prostatic Neoplasms 1 Port-Wine Stain 1 Pancreatic Neoplasms 1 Osteoma, Osteoid 1 Nevus of Ota 1 Neurofibromatoses 1 Neoplasm Metastasis 1 Mucositis 1 Lymphedema 1 Keratosis, Actinic 1 Hemangioma, Capillary 1 Head and Neck Neoplasms 1 Eye Neoplasms 1 Cholangiocarcinoma 1 Carcinoma, Squamous Cell 1 Bile Duct Neoplasms 1 Atrophy 1

Interventions

Carboplatin 26 Etoposide 22 Vincristine 18 Melphalan 14 Filgrastim 14 Topotecan 11 Granulocyte Colony-Stimulating Factor 10 Cyclophosphamide 9 Thiotepa 7 Cryotherapy 7 Peripheral Blood Stem Cell Transplantation 4 Mesna 4 Drug Therapy 4 Busulfan 4 Radiotherapy 3 Ifosfamide 3 Doxorubicin 3 Brachytherapy 3 Watchful Waiting 2 Temozolomide 2 Platinum Compounds 2 Magnetic Resonance Imaging 2 Eye Enucleation 2 Cisplatin 2 Blood Specimen Collection 2 trioctyl phosphine oxide 1 sargramostim 1 racotumomab 1 pembrolizumab 1 pegylated granulocyte colony-stimulating factor 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02866136 2025-11-24

RETINO2011

Institut Curie

Phase 2 Active not recruiting

Other solid neoplasm

Retinoblastoma, Retinal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡